The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Wright Timothy Michael since 2017.
The trader's CIK number is 1686178.
At the time of the last reporting, Wright Timothy Michael was the Chief R & D Officer of Regulus Therapeutics Inc.. (stock ticker symbol RGLS).
Also see all insider trading activities at Regulus Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | RGLS | 274,725 | $249,999 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-07-25 | RGLS | Buy | 274,725 | .91 | 249,999 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wright Timothy Michael (Chief R & D Officer of Regulus Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.